Literature DB >> 10816521

Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.

P M Schlievert1, L M Jablonski, M Roggiani, I Sadler, S Callantine, D T Mitchell, D H Ohlendorf, G A Bohach.   

Abstract

Staphylococcus aureus and Streptococcus pyogenes express pyrogenic toxin superantigens (PTSAgs) that are associated with toxic shock syndrome (TSS) and staphylococcal food poisoning (SFP). Most PTSAgs cause TSS in deep-tissue infections, whereas only TSS toxin 1 (TSST-1) is associated with menstrual, vaginal TSS. In contrast, SFP has been linked only with staphylococcal enterotoxins (SEs). Because of the differential abilities of PTSAgs to cause systemic or localized symptoms in a site-dependent manner, the present study was undertaken to assess the toxins' abilities to cross mucosal barriers. The activity of three PTSAgs when delivered orally, vaginally, or intravenously to rabbits and orally to monkeys was investigated. TSST-1 induced shock via all three routes in rabbits. Although active when administered intravenously, SEC1 and streptococcal pyrogenic exotoxin A (SPEA) did not cause symptoms when administered orally or vaginally. Only SEC1 induced emesis in the monkey feeding assay. TSST-1, albeit less stable than SEC1 and SPEA to pepsin, induced diarrhea in monkeys. Our results may explain the unique association of TSST-1 with menstrual TSS and why SPEA is only rarely associated with TSS after pharyngitis, despite being highly associated with TSS after subcutaneous infections. Finally, our studies indicate that enterotoxicity in SFP is not the result of superantigenicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816521      PMCID: PMC97652          DOI: 10.1128/IAI.68.6.3630-3634.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B.

Authors:  G Alber; D K Hammer; B Fleischer
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

2.  Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins.

Authors:  C J Hovde; S P Hackett; G A Bohach
Journal:  Mol Gen Genet       Date:  1990-01

3.  Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.

Authors:  P K Lee; B N Kreiswirth; J R Deringer; S J Projan; W Eisner; B L Smith; E Carlson; R P Novick; P M Schlievert
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

4.  Structure of toxic shock syndrome toxin 1.

Authors:  G S Prasad; C A Earhart; D L Murray; R P Novick; P M Schlievert; D H Ohlendorf
Journal:  Biochemistry       Date:  1993-12-21       Impact factor: 3.162

5.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Evidence for two molecular forms of streptococcal erythrogenic toxin. Conversion to a single form by 2-mercaptoethanol.

Authors:  C Nauciel; J Blass; R Mangalo; M Raynaud
Journal:  Eur J Biochem       Date:  1969-11

Review 7.  Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

Authors:  G A Bohach; D J Fast; R D Nelson; P M Schlievert
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

8.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

Authors:  J A Mollick; G G Miller; J M Musser; R G Cook; D Grossman; R R Rich
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Group A streptococcal bacteremia in a mid-south children's hospital.

Authors:  R J Leggiadro; M C Bugnitz; B A Peck; G S Luedtke; M H Kim; E L Kaplan; P M Schlievert
Journal:  South Med J       Date:  1993-06       Impact factor: 0.954

View more
  33 in total

1.  Identification of a transcytosis epitope on staphylococcal enterotoxins.

Authors:  Jeffrey W Shupp; Marti Jett; Carol H Pontzer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Characterization of Staphylococcus aureus enterotoxin L.

Authors:  Paul M Orwin; J Ross Fitzgerald; Donald Y M Leung; Juan A Gutierrez; Gregory A Bohach; Patrick M Schlievert
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.

Authors:  Jingru Li; Wenliang Wang; Stacey X Xu; Nathan A Magarvey; John K McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

4.  A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.

Authors:  Dong-Liang Hu; Jing-Chun Cui; Katsuhiko Omoe; Hiroshi Sashinami; Yuichi Yokomizo; Kunihiro Shinagawa; Akio Nakane
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

6.  Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.

Authors:  A Gravet; P Couppié; O Meunier; E Clyti; B Moreau; R Pradinaud; H Monteil; G Prévost
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates.

Authors:  Agnieszka K Zielinska; Karen E Beenken; Lara N Mrak; Horace J Spencer; Ginell R Post; Robert A Skinner; Alan J Tackett; Alexander R Horswill; Mark S Smeltzer
Journal:  Mol Microbiol       Date:  2012-10-17       Impact factor: 3.501

9.  Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.

Authors:  Roderick A MacPhee; Wayne L Miller; Gregory B Gloor; John K McCormick; Jo-Anne Hammond; Jeremy P Burton; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

10.  Superantigen profiling of Staphylococcus aureus infective endocarditis isolates.

Authors:  Jin-Won Chung; Melissa J Karau; Kerryl E Greenwood-Quaintance; Alessandro D Ballard; Ashenafi Tilahun; Shahryar Rostamkolaei Khaleghi; Chella S David; Robin Patel; Govindarajan Rajagopalan
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-17       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.